Kansai Forum] How to Attack Globalizing Infectious Diseases June 21, 2020 (Sun.) 10:00 @ Kobe

Riverness will sponsor the event.Hyper Interdisciplinary Conference in Kansai Forum 2020(Sunday, June 21, 2020), a panel discussion on "How to Attack Globalizing Infectious Diseases" (session partner: Rohto Pharmaceutical Co., Ltd.) will be held within the

With the simplification of transportation, the international movement of people and goods has become more active, and the definition of national borders has become blurred. It is no exaggeration to say that the history of mankind has been built on the battle against infectious diseases, but the COVID-19 outbreak has triggered a renewed awareness of the threat of infectious diseases that originate somewhere on the planet and spread globally in the blink of an eye. At the same time, research and development of medicines, treatment methods, and prevention methods have evolved, and we are now faced with the need to respond not only in our own countries but also globally. In this session, we will hear from Rohto Pharmaceutical Co., Ltd. which is developing regenerative medicine and prevention areas globally, MyCan Technologies, Inc. which develops research materials for drug discovery and vaccines using regenerative medicine, and Japan and foreign countries investing in joint research and development for infectious diseases in developing countries.GHIT Fundwill gather to discuss the future of infectious disease control.

We have prepared a program of discussions among researchers, venture companies, and large corporations from various perspectives, not limited to the themes of this session. We are currently accepting applications for audience participation. Please visit the conference website (see below).

How to Attack Globalizing Infectious Diseases
Session Partner: Rohto Pharmaceutical Co.

Date: Sunday, June 21, 2020, 10:00 - 11:00
Venue: Kobe International Conference Center (6-9-1 Minatojima-nakamachi, Chuo-ku, Kobe 650-0046, Japan)
Closest Station: Shimin Hiroba Station (Portliner)
Map:https://kobe-cc.jp/ja/visitors/access/

<Speakers

General Manager, Basic Research and Development Department, Rohto Pharmaceutical Co.
Tsuyoshi Ishii
After graduating from the Faculty of Pharmaceutical Sciences at Osaka University and completing the master's program at the same university, he joined Rohto Pharmaceutical in 1997 and was assigned to the Research and Development Division, where he was mainly engaged in basic research on skin aging and the development of functional cosmetics. In 2013, he joined the company's Regenerative Medicine Research and Planning Department, where he was involved in the development of regenerative medicine products. He has been in his current position at the company's Research Village Kyoto since 2017.

Leader, Biological Control Group, Basic Research and Development Department, Rohto Pharmaceutical Co.
Takahiro Kurose
In 2006, he completed the Master's course at the Graduate School of Pharmaceutical Sciences, Hokkaido University. In 2013, he was transferred to the Sanford-Burnham Research Center in the U.S., where he participated in a project to discover new drug seeds to inhibit retinal nerve cell death. In 2016, he assumed his current position and is engaged in project management of pharmacological research in ophthalmology drug development.

CEO and Representative Director, MyCan Technologies, Inc.
Kazuo Miyazaki
Graduated from Tokyo University of Science, Graduate School of Science. Specialized in synthetic organic chemistry and regenerative medicine. For about 20 years, he worked for a pharmaceutical company conducting exploratory research on small molecule compounds for vascular, renal, and central nervous system diseases, as well as small molecule compounds to complement regenerative medicine. His encounter with malaria, dengue fever, and other infectious diseases in India led him to establish MyCan Technologies, Inc. in 2016. Aiming to solve the challenges of special blood-borne infections using regenerative medicine technologies.

GHIT Fund (Global Health Technology Fund)
Senior Director, Investment Strategy and Business Development
Kei Katsuno
He oversees the investment and development strategy of the GHIT Fund. After working as a physician at the National Center for Global Health and Medicine (formerly the National Center for Global Health and Medicine), he earned a Master of Public Health (MPH) degree from the Johns Hopkins University School of Public Health in the United States as a Fulbright Scholar. He then worked at the East West Center and the World Bank (as a health specialist) before assuming his current position in 2013. He graduated from the University of Tokyo School of Medicine with a Bachelor's degree in Medicine. He is board certified in both Japan and the United States (ECFMG). He is a Fellow of the U.S.-Japan Leadership Program.

.

Director, Knowledge Foundation Research Center, Liverness, Inc.
Hiroyuki Takahashi
D. from Yokohama City University in 2009. D. in Science, focusing on creating new research projects between industry and young researchers, including the launch of the "Liberace Research Fund" for young researchers under the age of 40. In addition, he continues to organize the "Super Interdisciplinary Society," a place to generate new knowledge and seeds for research and development by combining individual knowledge, technology, and passion for problem solving without being bound by the framework of academia.

-----------------------------------------------
The Japan Society for Hyper-Differential Research Kansai Forum 2020 Overview
------------------------------------------------

Conference theme: The Circle of Knowledge for a Sustainable Society - Medicine and Environment in the After Corona
Date and time of the event:
June 21 (Sun.) 9:00-17:30
Organized by: Liverness Co.
Venue: Kobe International Conference Center
Participation fee: Free for academics and presenters, 50,000 yen for companies
　　　　*Free of charge for partners and those willing to serve as judges
Convention URL:https://hic.lne.st/conference/osaka2020/

＜Contact us for more information.
LIVANES Corporation, Osaka Head Office (Attn: Nakaemasa, Isogai)
TEL：050-1743-9799 E-mail：[email protected]